Patch testing in fixed drug eruptions-a 20-year review

Contact Dermatitis

Volumn 65, Issue 4, 2011, Pages 195-201

  Andrade, Pedro ^a   Brinca, Ana ^a   Gonçalo, Margarida ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

allopurinol; fixed drug eruption; NSAID; oral rechallenge; patch tests

Indexed keywords

'TRITICUM'; ACETYLSALICYLIC ACID; ALLOPURINOL; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAMAZEPINE; CASTILIUM; CD; CELECOXIB; CETIRIZINE; CLOBAZAM; COTRIMOXAZOLE; DICLOFENAC; DILTIAZEM; DIPYRONE; DIPYRONE MAGNESIUM; DOXYCYCLINE; ETORICOXIB; EXXIV; FUSIDIC ACID; HIDROXYZINE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LEVOCETIRIZINE; NAPROXEN; NIMESULIDE; PARACETAMOL; PIROXICAM; RELMUS; SPIRAMYCIN; THIOCOLCHICOSIDE; TRAZODONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ALLERGIC REACTION; CLINICAL EVALUATION; CROSS REACTION; DIAGNOSTIC VALUE; DRUG RECHALLENGE; EDEMA; ERYTHEMA; FEMALE; FIXED DRUG ERUPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATCH TEST; RETROSPECTIVE STUDY; REVIEW;

ACETAMINOPHEN; ADULT; AGED; ALLOPURINOL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRETICS; CETIRIZINE; CROSS REACTIONS; DRUG ERUPTIONS; FEMALE; GOUT SUPPRESSANTS; HISTAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 80052782343     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2011.01946.x     Document Type: Review

References (34)

1. Brahimi N, Routier E, Raison-Peyron N et al., A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol 2010: 20: 461-464.
2. Lee A Y., Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol 2000: 1: 277-285.
3. Sehgal V N, Srivastava G., Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol 2006: 45: 897-908. (Pubitemid 44145022)
4. Ozkaya E., Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008: 6: 181-188. (Pubitemid 351361060)
5. Barbaud A., Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005: 209: 209-216. (Pubitemid 40568653)
6. Lammintausta K, Kortekangas- Savolainen O., The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005: 152: 968-974. (Pubitemid 40704937)
7. Gonçalo M, Oliveira H S, Fernandes B, Robalo-Cordeiro M, Figueiredo A., Topical provocation in 31 cases of fixed drug eruption. Exogenous Dermatol 2002: 1: 81-86.
8. Lee A Y., Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 1998: 38: 258-260.
9. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A., Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001: 45: 321-328. (Pubitemid 34056345)
10. Assouère M N, Mazereeuw-Hautier J, Bonafé J L., Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: cetirizine and hydroxyzine. Ann Dermatol Venereol 2002: 129: 1295-1298.
11. Cravo M, Gonçalo M, Figueiredo A., Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives. Int J Dermatol 2007: 46: 760-762. (Pubitemid 47046201)
12. Gastaminza G, Echechipia S, Navarro J A, Fernandéz de Corrés L., Fixed drug eruption to piroxicam. Contact Dermatitis 1993: 28: 43-44.
13. Ordoqui E, De Barrio M, Rodríguez V M, Herrero T, Gil P J, Baeza M L., Cross-sensitivity among oxicams in piroxicam-caused fixed drug eruption: two case reports. Allergy 1995: 50: 741-744.
14. Valsecchi R, Cainelli T., Nonpigmenting fixed drug eruption to piroxicam. J Am Acad Dermatol 1999: 21: 1300.
15. Oliveira H S, Gonçalo M, Reis J P, Figueiredo A., Fixed drug eruption to piroxicam. Positive patch tests with cross-sensitivity to tenoxicam. J Dermatol Treat 1999: 10: 209-212. (Pubitemid 29438084)
16. Strom B L, Schinnar R, Apter A J, Margolis D J, Lautenbach E, Hennessy S, Biker W B, Pettitt D., Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003: 349: 1628-1635. (Pubitemid 37288569)
17. Zawodniak A, Lochmatter P, Beeler A, Pichler W J., Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol 2010: 153: 152-156.
18. Mizukawa Y, Shiohara T., Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 2009: 9: 71-77.
19. Morais P, Baudrier T, Mota A, Cunha A P, Cadinha S, Barros A M, Azevedo F., Nonpigmented fixed drug eruption induced by esomeprazole. Cutan Ocul Toxicol 2010: 29: 217-220.
20. Galindo P A, Borja J, Feo F, Gómez E, Encinas C, García R., Nonpigmented fixed drug eruption caused by paracetamol. J Investig Allergol Clin Immunol 1999: 9: 399-400. (Pubitemid 30052828)
21. Bigby M, Stern R., Cutaneous reactions to nonsteroidal anti-inflammatory drugs. J Am Acad Dermatol 1985: 12: 866-876. (Pubitemid 15052483)
22. Alanko K., Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis 1994: 31: 25-27. (Pubitemid 24193850)
23. Robalo-Cordeiro M, Gonçalo M, Fernandes B, Oliveira H, Figueiredo A., Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 2000: 43: 307.
24. Andrade P, Gonçalo M., Fixed drug eruption caused by etoricoxib-2 cases confirmed by patch testing. Contact Dermatitis 2011: 64: 118-120.
25. Ozkaya-Bayazit E., Topical provocation in fixed drug eruption due to metamizol and naproxen. Clin Exp Dermatol 2004: 29: 419-422. (Pubitemid 38980379)
26. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G., Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis 1999: 41: 185-189. (Pubitemid 29427908)
27. Friedmann P S, Ardern-Jones M., Patch testing in drug allergy. Curr Opin Allergy Clin Immunol 2010: 10: 291-196.
28. Hadgraft J, Whitefield M, Rosher P H., Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol 2003: 16: 137-142. (Pubitemid 36407888)
29. Oleaga J M, Aguirre A, González M, Diaz-Pérez J L., Topical provocation of fixed drug eruption due to sulphamethoxazole. Contact Dermatitis 1993: 29: 155. (Pubitemid 23256090)
30. Ozkaya-Bayazit E, Güngör H., Trimethoprim-induced fixed drug eruption: positive topical provocation on previously involved and uninvolved skin. Contact Dermatitis 1998: 39: 87-88. (Pubitemid 28410020)
31. Braden G L, Warzynski M J, Golightly M, Ballow M., Cell-mediated immunity in allopurinol-induced hypersensitivity. Clin Immunol Immunopathol 1994: 70: 145-151. (Pubitemid 24064942)
32. Emmerson B T, Hazelton R A, Frazer I H., Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum 1988: 31: 436-440. (Pubitemid 18091669)
33. Hamanaka H, Mizutani H, Nouchi N, Shimizu Y, Shimizu M., Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol. Clin Exp Dermatol 1998: 23: 32-34. (Pubitemid 28218196)
34. Vieira R, Gonçalo M, Figueiredo A., Testes epicutâneos ao alopurinol e oxipurinol em doentes com toxidermias ao alopurinol. Trab Soc Port Dermatol Venereol 2004: 62: 247-253.